Boerma E J
Department of Surgery, St. Joannes de Deo Hospital, Haarlem, The Netherlands.
Surgery. 1990 Sep;108(3):572-80.
We found mentions of 581 resections of hilar bile duct cancer in the literature to January 1989. Resection in 499 patients, reported or updated since 1980, resulted in an operative mortality of 12% and a 5-year survival rate of 13%. Resections confined to the hepatic duct confluence or extended to the quadrate lobe led to an 8% operative mortality and a 7% 5-year survival rate, although resections combined with major liver resection gave a 15% operative mortality and a 17% 5-year survival rate. Despite the best treatments available, present-day resection modalities are usually still not radical. Extension of resection in the retrohilar and hepatoduodenal direction might further improve the long-term surgical results.
截至1989年1月，我们在文献中发现了581例肝门部胆管癌切除术的相关报道。1980年以来报道或更新的499例患者的切除术，手术死亡率为12%，5年生存率为13%。局限于肝管汇合部或延伸至方叶的切除术，手术死亡率为8%，5年生存率为7%，尽管联合肝大部切除术的手术死亡率为15%，5年生存率为17%。尽管有最佳的现有治疗方法，但目前的切除方式通常仍不彻底。向肝门后方和肝十二指肠方向扩大切除范围可能会进一步改善长期手术效果。
